Chase Pharmaceuticals Corp — Form D
Chase Pharmaceuticals Corp of WASHINGTON, DC, a company, filed a Form D exempt-offering notice with the SEC on 2015-08-20. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2015-08-20
- Form: D
- Accession: 0001140361-15-032968
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $3.0M
- Investors: 12
- Date of first sale: 2015-08-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-246193
Issuer
- Name: Chase Pharmaceuticals Corp
- CIK: 0001509008
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 1825 K Street, NW, WASHINGTON, DC, 20006
- Phone: 202-792-4621
Officers, directors & promoters (22)
| Name | Role | Location |
|---|
| N. Greg Parekh | Director | Washington, DC |
| John M Siebert | Executive Officer | Hayward, CA |
| Richard P Dulik | Executive Officer | Washington, DC |
| Kathleen N Clarence-Smith | Executive Officer | Washington, DC |
| Thomas N Chase | Director | Washington, DC |
| Thomas N Chase | Executive Officer | Washington, DC |
| John M Siebert | Director | Hayward, CA |
| Vikram M Sudarsan | Director | Washington, DC |
| Raphael M Wisniewski | Director | Washington, DC |
| Stephen N Cunningham | Director | Washington, DC |
| Nayan Greg Parekh | Director | Washington, DC |
| Karoly N Nikolich | Director | Washington, DC |
| Douglas Ingram | Director | Washington, DC, DC |
| Douglas Ingram | Executive Officer | Washington, DC, DC |
| Raphael N Wisniewski | Director | Washington, DC |
| Greg N Parekh | Director | Washington, DC |
| Vikram N Sudarsan | Director | Washington, DC |
| John M Reher | Director | Burlingame, CA |
| John M Reher | Executive Officer | Burlingame, CA |
| Kathleen P Clarence-Smith | Director | Washington, DC |
| Kathleen P Clarence-Smith | Executive Officer | Washington, DC |
| Karoly M Nikolich | Director | Burlingame, CA |
Other filings by this issuer (6)
More